Regeneron Pharmaceuticals (REGN)
Stockholders Equity
$31.71B
Quarterly · Period ending: · USD
REGN Stockholders Equity
Latest reported$31.26Bperiod ending
Latest reported$31.26Bperiod ending
REGN FY Shareholders Equity ($12.20M → $31.26B)
Annual shareholders equity
High-resolution chart · PNG
REGN stockholders equity history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stockholders Equity (USD) |
|---|---|
| 31,256,900,000 | |
| 29,353,600,000 | |
| 25,973,100,000 | |
| 22,664,000,000 | |
| 18,768,800,000 | |
| 11,025,300,000 | |
| 11,089,700,000 | |
| 8,757,300,000 | |
| 6,144,078,000 | |
| 4,449,245,000 | |
| 3,654,837,000 | |
| 2,542,325,000 | |
| 1,952,076,000 | |
| 1,245,385,000 | |
| 485,732,000 | |
| 527,815,000 | |
| 396,762,000 | |
| 418,852,000 | |
| 460,267,000 | |
| 216,624,000 | |
| 114,002,000 | |
| 182,543,000 | |
| 137,643,000 | |
| 145,981,000 | |
| 266,355,000 | |
| 182,130,000 | |
| 109,500,000 | |
| 131,200,000 | |
| 138,900,000 | |
| 106,900,000 | |
| 67,900,000 | |
| 67,100,000 | |
| 98,400,000 | |
| 87,200,000 | |
| 106,200,000 | |
| 12,200,000 |